Red Abbey Venture Partners
Red Abbey Venture Partners is a life sciences investment firm that was founded in 2004. Since that time, it has invested in 15 privately
Business Model:
Revenue: $22.3M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Red Abbey Venture Partners Information
Geographic Data
Address: 10751 Falls Road Suite 300
City: Baltimore
State: MD
Zip: 21093
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Red Abbey Venture Partners is a life sciences investment firm that was founded in 2004. Since that time, it has invested in 15 privately held and 9 publicly traded life sciences companies. Mission is to generate superior, risk-adjusted returns by investing in young companies that are developing the next generation of drugs and devices, as well as companies that are supporting these efforts with novel tools and products. Specifically, seeking to invest across the life sciences spectrum, which includes biotechnology, specialty pharmaceutical, medical device, diagnostics and research tools companies.
Contact Phone:
+14104947401
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2005 | Anacor Pharmaceutical | Series C | 25M |
| 8/2005 | Alba Therapeutics | Series A | 30M |
| 12/2022 | Perceiv AI | Seed Round | 1.5M |
| 10/2005 | Nereus Pharmaceuticals | Series D | 0 |
| 12/2015 | Cohero Health | Seed Round | 0 |
| 10/2008 | MacroGenics | Series D | 25M |
| 2/2007 | Advanced BioHealing | Series C | 0 |
| 8/2006 | Kemia | Series C | 0 |
| 6/2006 | CoGenesys | Series A | 55M |
| 10/2008 | Corridor Pharmaceuticals | Seed Round | 0 |
| 4/2008 | Stromedix | Series B | 25M |
| 10/2004 | MacroGenics | Series B | 30.5M |
| 5/2006 | MacroGenics | Series C | 45M |
| 4/2006 | Sirtris Pharmaceuticals | Series C | 37M |
| 10/2014 | Atopix Therapeutics | Series A | 0 |
| 6/2010 | Corridor Pharmaceuticals | Series A | 0 |
| 10/2009 | Corridor Pharmaceuticals | Series A | 0 |
| 11/2009 | Oxagen | Series C | 0 |
| 5/2005 | Oxagen | Series B | 0 |
| 1/2006 | Cytokinetics | Post-IPO Equity | 33M |
| 12/2015 | Cohero Health | Seed Round | 0 |
| 10/2014 | Atopix Therapeutics | Series A | 0 |
| 6/2010 | Corridor Pharmaceuticals | Series A | 0 |
| 11/2009 | Oxagen | Series C | 0 |
| 10/2009 | Corridor Pharmaceuticals | Series A | 0 |
| 10/2008 | Corridor Pharmaceuticals | Seed Round | 0 |
| 10/2008 | MacroGenics | Series D | 0 |
| 4/2008 | Stromedix | Series B | 0 |
| 2/2007 | Advanced BioHealing | Series C | 0 |
| 8/2006 | Kemia | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
